Article Figures & Data
Figures
Tables
Patient demographic and clinical informationa
No. Age (yr)/Sex Primary Tumor (grade) No. RT and Timing (mo completed prior to imaging) Chemotherapy 1 31/M AA 60 Gy 3D-C (9) T-RT (III) 25 Gy IMRT (2) 2 58/M GBM 54 Gy 3D-C (22) T-RT (IV) 12 Gy GK (5) 3 36/M GBM 60 Gy IMRT (3) T-RT (IV) 4 56/M GBM 60 Gy IMRT (23) T-RT (IV) 30 Gy IMRT (10) 5 45/F GBM 60 Gy 3D-C (26) T-RT (IV) 6 44/M GBM 59.4 Gy IMRT (12) T-RT (IV) 7 50/M GBM 37.5 Gy whole-brain RT (8) T-RT (IV) 30 Gy IMRT (5) 8 42/M GBM (DD-IV) 60 Gy IMRT (60) T-RT 9 59/M GBM 59.4 Gy IMRT (13) T-RT (IV) 10 60/F Ana. ODG 10 Gy GK (12) T-RT (III) 11 54/M AA 59.4 Gy IMRT (11) T-RT (III) 12 38/M Ana. GG 54 Gy IMRT (24) T-RT (III) 12 Gy GK (11) 13 50/M GBM (IV) 60 Gy IMRT (1) T-RT 14 42/M Ana. OA 59.4 Gy IMRT (29) T-RT (DD-III) 15 25/M AA None None (DD-III) 16 48/F OA 59.4 Gy 3D-C (76) T-RT (III) 17 53/M Ana. ODG None None (DD-III) 18 62/F GBM 60 Gy 3D-C (8) T-RT (IV) 12 Gy GK (7) 19 25/M GBM 60 Gy 3D-C (19) T-RT & B (IV) 20 46/F Ana. ODG None None (DD-III) 21 40/F AA None None (III) 22 49/M AA None None (DD-III) 23 73/F GBM 34 Gy IMRT (1) T-RT (IV) 24 34/M AA None None (DD-III) -
Note:—AA indicates anaplastic astrocytoma; Ana. GG, anaplastic ganglioglioma; Ana. ODG, anaplastic oligodendroglioma; Ana. OA, anaplastic oligoastrocytoma; DD = dedifferentiated from previous low-grade tumor; IMRT, intensity-modulated radiation therapy; GK, gamma knife; 3D-C, 3D conformal; T-RT, temodar (with initial radiation therapy); B, prior bevacizumab therapy; RT, radiation therapy.
-
↵a All patients underwent prior surgical treatment for their primary tumors.
-
In this issue
Jump to section
Related Articles
Cited By...
- Identification of a Single-Dose, Low-Flip-Angle-Based CBV Threshold for Fractional Tumor Burden Mapping in Recurrent Glioblastoma
- Image-localized biopsy mapping of brain tumor heterogeneity: A single-center study protocol
- Image-localized Biopsy Mapping of Brain Tumor Heterogeneity: A Single-Center Study Protocol
- Voxelwise and Patientwise Correlation of 18F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naive Diffuse Gliomas with Different Molecular Subtypes
- Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies
- Reduction of intratumoral brain perfusion by noninvasive transcranial electrical stimulation
- Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors
- Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning
- Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas
- Comparison of the Effect of Vessel Size Imaging and Cerebral Blood Volume Derived from Perfusion MR Imaging on Glioma Grading
- Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma
- Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma
- Arterial Spin-Labeling Perfusion MRI Stratifies Progression-Free Survival and Correlates with Epidermal Growth Factor Receptor Status in Glioblastoma
- Assessment of Angiographic Vascularity of Meningiomas with Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted Imaging and Diffusion Tensor Imaging